PUNE, India, October 10, 2022 (GLOBE NEWSWIRE) — The Market size for oligonucleotide synthesis is growing significantly as it benefits businesses from accelerating their speed through interaction with the environment.
Fortune Business Insights™ examined these answers in a research report titled “Oligonucleotide Synthesis Market, 2022-2029.”
Increasing R&D investment in oligonucleotide synthesis by leading market players is driving the global oligonucleotide synthesis market, according to Fortune Business Insights. The reduced cost of the new microchip-based oligonucleotide synthesis is expected to boost the growth of the global oligonucleotide synthesis market.
Request a sample copy of the research report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/oligonucleotide-synthesis-market-101020
Conference held for discussion Oligonucleotide-based therapeutics Will encourage growth
DIA/FDA Conference on Oligonucleotide-Based Therapeutics in North Bethesda, addressing quality risk management, manufacturing advances, specifications, formulation issues, oligonucleotide pharmacokinetics, non-clinical reviews to support drug development and clinical advances in therapeutic targets, study design and safety for antisense, siRNA , mRNA and microRNA therapies. The DIA/FDA conference on oligonucleotide-based therapeutics is likely to fuel the global growth of oligonucleotide synthesis due to the open discussion with industry and health authorities to inform, educate and provide insight into the advances in the development of oligonucleotide-based therapeutic products -Replace base.
In addition, the 14th The annual meeting of the Oligonucleotide Therapeutic Society is also expected to enable the growth of the global oligonucleotide synthesis market. For example, the 14th Annual Meeting of the Oligonucleotide Therapeutics Society was held in Seattle, which provided data on the therapeutic applications of oligonucleotides.
